Cargando…

Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Steffes, Lea C., Austin, Eric D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867360/ https://www.ncbi.nlm.nih.gov/pubmed/35103566 http://dx.doi.org/10.1513/AnnalsATS.202108-975ED

Ejemplares similares

Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION
por: Cascino, Thomas M., et al.
Publicado: (2021)

When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
por: Niedermeyer, Shannon, et al.
Publicado: (2023)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Never Get Ahead of Others
por: Lee, Choon-Ki
Publicado: (2010)

Getting Ahead of St. Paul
Publicado: (1890)

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension
por: Sulica, Roxana, et al.
Publicado: (2019)

Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome
por: Takeuchi, Kimikazu, et al.
Publicado: (2017)

‘Getting to Zero’: a steep path ahead
por: Satyanarayana, K.
Publicado: (2011)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Ten Simple Rules for Getting Ahead as a Computational Biologist in Academia
por: Bourne, Philip E.
Publicado: (2011)

Getting Ahead of the Virus
por: Hatchett, Richard
Publicado: (2021)

End Stage Takes Center Stage in Pulmonary Arterial Hypertension
por: Hamid, Rizwan, et al.
Publicado: (2019)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)

Upfront triple oral combination therapy including selexipag in a high-risk patient with idiopathic pulmonary arterial hypertension: a case report
por: Rossi, Serena, et al.
Publicado: (2020)

Getting ahead by staying still
por: Wells, William A.
Publicado: (2005)

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study
por: Sato, Takahiro, et al.
Publicado: (2017)

Sex Hormones across the Menstrual Cycle in Pulmonary Arterial Hypertension: Adding a New Layer of Complexity
por: Austin, Eric D.
Publicado: (2021)

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension
por: Ivy, D. Dunbar, et al.
Publicado: (2019)

Getting ahead of the game: in-hospital initiation of HFrEF therapies
por: Biegus, Jan, et al.
Publicado: (2022)

Emerging infections: getting ahead of the curve.
por: Satcher, D
Publicado: (1995)

Your next role: how to get ahead and get promoted
por: O'Keeffe, Niamh
Publicado: (2016)

Lung transplant in familial pulmonary fibrosis: the road ahead
por: Esposito, Anthony Joseph, et al.
Publicado: (2020)

Pediatric Surgery: Is It Growing?
por: Basak, Dhananjay
Publicado: (2019)

Get Noticed to Get Ahead: The Impact of Personal Branding on Career Success
por: Gorbatov, Sergey, et al.
Publicado: (2019)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Chronic obstructive pulmonary disease: Indian guidelines and the road ahead
por: Koul, Parvaiz A.
Publicado: (2013)

GET AHEAD! SURGERY: 250 SBAS FOR FINALS
por: Spence, Roy AJ
Publicado: (2009)

Highlight: Epigenetics Help Hydra Get Ahead
por: McGrath, Casey
Publicado: (2021)

Comparing outcomes between neoadjuvant hormonal therapy followed by prostatectomy versus upfront prostatectomy in high-risk prostate cancer: The road ahead
por: Bhargava, Priyank
Publicado: (2023)

The way ahead
por: Twentyman, Peter, et al.
Publicado: (1991)

Marching ahead…
por: Nayak, Barun Kumar
Publicado: (2009)

Forging Ahead
por: Kelly, Barry E
Publicado: (2010)

Moving ahead
por: Jagannathan, Mukund
Publicado: (2015)

Challenges ahead
por: Muglia, Valdair F
Publicado: (2023)

Looking Ahead
Publicado: (1889)

Pulmonary Arterial Hypertension: Combination Therapy in Practice
por: Burks, Marsha, et al.
Publicado: (2018)

Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey
por: Dutilleux, Tanguy, et al.
Publicado: (2023)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g3b0asttrj50lt0n2icsudpgdo